Grantopen🌐 United StatesRFA-HL-26-017

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

National Institutes of Health

Details?

Posted: Nov 22, 2024
Response deadline: Dec 23, 2027, 12:00 AM UTC (529d)
Type: Grant
Category: 93.838, 93.233, 93.839, 93.855, 93.837
Status: open
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-HL-26-017

Doc Type: synopsis
Opp Status: posted

Similar open solicitations

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
United States · Nov 22, 2024
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
United States · Nov 22, 2024
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
United States · Nov 22, 2024
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
United States · Nov 22, 2024
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
United States · Nov 6, 2024
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
United States · Nov 6, 2024

Similar past solicitations

Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
United States · Jan 8, 2025
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
United States · Oct 31, 2023
Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
United States · Dec 30, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.